Topic - Viiv Healthcare

Related Stories

Patients use nebulizers during a test for the presence of TB, at the Tembalete, a U.S. funded Right to Care Clinic at the Helen Joseph Hospital in Johannesburg Wednesday, Dec 17, 2008. In a series of moves experts say signal a shift in how developing countries deal with pharmaceuticals, South Africa, Colombia and others have recently adopted a more combative approach towards drugmakers, pushing back on policies that deny treatment to millions of people with tuberculosis and HIV. (AP Photo/Denis Farrell, File)

South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs

Associated Press

These illustrations, provided by drugmaker ViiV Healthcare on Thursday, Dec. 10, 2020, shows a rendering of the packaging and vials containing its new HIV treatment, Cabenuva, approved by the U.S. Food and Drug Administration on Thursday, Jan. 21, 2021. U.S. regulators have approved the first long-acting combo drug for HIV, monthly shots that can replace the daily pills that have been used for decades to control infection with the AIDS virus. Thursday’s approval of Cabenuva is expected to make it easier for people to stay on track with their HIV medicines and to do so with more privacy(ViiV Healthcare via AP)

FDA approves 1st long-acting HIV drug combo, monthly shots

By MARILYNN MARCHIONE - Associated Press

Laboratory technicians test a blood sample for HIV infection at the Reproductive Health and HIV Institute (RHI) in Johannesburg, Thursday, Nov. 26 2020. The successful trials of a new injectable drug that needs to be taken every eight weeks to prevent HIV infection is being lauded on World AIDS Day as a turning point for the fight against a global health threat that's been eclipsed by the coronavirus pandemic. (AP Photo/Denis Farrell)

On World AIDS Day, South Africa finds hope in new treatment

By MOGOMOTSI MAGOME - Associated Press

Study finds long-acting shot helps women avoid HIV infection

By MARILYNN MARCHIONE - Associated Press